n
late
coronaviru
diseas
lead
sever
acut
respiratori
syndrom
sar
start
china
becom
pandem
respons
viru
design
cellular
receptor
angiotensinconvert
enzym
mostli
membranebound
homologu
angiotensinconvert
enzym
ace
gener
great
interest
interact
reninangiotensin
system
ra
well
medicin
commonli
use
block
ra
agent
ace
inhibitor
acei
angiotensin
ii
receptor
blocker
arb
wide
use
treatment
hypertens
heart
failur
chronic
kidney
diseas
diabet
ace
share
amino
acid
ident
differ
enzymat
select
importantli
function
express
primarili
lung
heart
kidney
enzym
play
key
role
ra
angiotensin
angi
whose
format
angiotensinogen
catalyz
renin
convert
downstream
hormon
oppos
hemodynam
effect
vasoconstrict
angiotensin
ii
angii
vasodil
angiotensin
ang
angii
ang
oppos
vascular
effect
via
separ
receptor
ma
respect
addit
role
antagonist
angiimedi
vasoconstrict
ang
also
studi
antifibrot
agent
nonsar
lung
diseas
thought
afford
protect
lung
injuri
depict
figur
ace
increas
circul
angii
increas
convers
angi
angii
contrast
decreas
circul
angii
divert
angi
format
ang
convert
angii
ang
angi
angii
regul
format
ace
angii
upregul
ace
downregul
express
hypertens
condit
vivo
vitro
major
entri
via
respiratori
system
ace
ratio
contrast
kidney
ace
ratio
approxim
given
virus
enter
via
lung
might
use
receptor
low
level
lung
might
help
reduc
entri
provid
evolutionari
advantag
surviv
despit
higher
level
observ
kidney
incid
acut
kidney
injuri
rel
low
contrast
incid
sever
lung
injuri
requir
mechan
ventil
observ
injuri
kidney
might
secondari
sepsi
hypotens
preinfect
kidney
patholog
wherea
kidney
might
still
exert
protect
effect
altern
intervent
increas
lung
might
detriment
patient
facilit
entri
viru
cell
enter
cell
bind
spike
protein
step
essenti
lung
injuri
intern
viru
deplet
membranebound
possibl
increas
angii
could
potenti
lung
injuri
angii
stimul
target
receptor
arb
contribut
significantli
lung
damag
experiment
model
blockad
classic
ra
pathway
either
acei
arb
similar
downstream
effect
angii
vasoconstrict
sodium
reabsorpt
aldosteron
secret
mechan
blockad
differ
effect
angi
angii
level
acei
increas
angi
level
perhap
ang
decreas
angii
wherea
arb
increas
level
angi
ang
angii
agent
act
ra
sympatholyt
betablock
direct
renin
inhibitor
lower
format
angi
therefor
angii
ang
focu
current
controversi
impact
ra
agent
sever
infect
subsequ
prognosi
anim
model
respons
arb
acei
heterogen
depend
agent
use
dose
organ
studi
overal
appear
arb
tend
increas
activ
experiment
model
sarscoronaviru
lung
injuri
despit
elev
tissu
level
angii
blockad
arb
losartan
attenu
sever
acut
lung
injuri
pulmonari
edema
line
find
hypertens
human
show
arb
olmesartan
increas
urinari
level
taken
togeth
howev
current
understand
effect
acei
arb
viralmedi
lung
cardiac
injuri
preliminari
insuffici
inform
definit
statement
chang
respons
drug
would
affect
urgent
need
effect
therapeut
intervent
ongo
pandem
led
consider
specul
regard
impact
ra
blockad
hypothes
use
arb
increas
could
potenti
benefici
treat
increas
could
prevent
lung
damag
preserv
despit
entri
cell
altern
increas
could
potenti
opposit
result
promot
viral
port
entri
cell
case
seri
china
hospit
patient
confirm
found
circul
level
angii
significantli
elev
neg
correl
viral
load
lung
injuri
determin
oxygen
signific
observ
unclear
given
measur
difficulti
high
variabl
angii
measur
human
also
possibl
confound
hemodynam
alter
associ
critic
ill
hypotens
stimul
ra
present
interpret
clinic
observ
regard
ra
patient
difficult
interpret
context
sepsi
viral
infect
pharmacolog
effect
treatment
nevertheless
notion
arb
may
mitig
potenti
low
angii
milieu
consider
interest
given
lack
clariti
effect
acei
arb
interact
develop
current
possibl
recommend
use
either
acei
arb
purpos
treat
need
shortterm
discontinu
delay
initi
acei
arb
patient
otherwis
control
mild
hypertens
stabl
heart
failur
stabl
chronic
kidney
diseas
unlik
neg
consequ
howev
longerterm
effect
need
becom
clarifi
time
current
author
continu
administ
drug
patient
unless
critic
ill
high
risk
hypotens
kidney
injuri
thu
present
effect
either
acei
arb
patient
known
infect
sever
ill
viru
infect
remain
unknown
unclear
whether
differ
acei
arb
clinic
relev
patient
clarif
role
express
prognost
implic
acei
arb
clinic
outcom
urgent
need
observ
studi
big
data
approach
evalu
associ
ra
blockad
sever
potenti
start
point
addit
experiment
studi
examin
complex
relationship
ra
would
greatli
benefit
futur
treatment
approach
deidentifi
patient
data
outcom
use
ra
agent
infect
place
web
made
publicli
avail
help
research
develop
drug
target
may
potenti
treat
assist
understand
role
diseas
march
regist
clinic
trial
studi
target
ra
appear
withdrawn
author
declar
compet
interest
